These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 302045)

  • 1. Cell-mediated immunity to measles virus in subacute sclerosing panencephalitis.
    Yamanaka T; Chiba S; Nakao T; Okabe N; Takahashi N
    Tohoku J Exp Med; 1977 Jun; 122(2):175-81. PubMed ID: 302045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.
    Kreth WH; Käckell MY; ter Meulen V
    J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis.
    Steele RW; Fuccillo DA; Hensen SA; Vincent MM; Bellanti JA
    J Pediatr; 1976 Jan; 88(1):56-62. PubMed ID: 812971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxicity against measles virus in SSPE. I. Enhancement by antibody.
    Kreth HW; Meulen V
    J Immunol; 1977 Jan; 118(1):291-5. PubMed ID: 830752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of measles virus antigen(s) in peripheral lymphocytes from patients with subacute sclerosing panencephalitis.
    Wrzos H; Kulczycki J; Laskowski Z; Matacz D; Brzosko WJ
    Arch Virol; 1979; 60(3-4):291-7. PubMed ID: 389202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis.
    Dhib-Jalbut S; Jacobson S; McFarlin DE; McFarland HF
    Ann Neurol; 1989 Mar; 25(3):272-80. PubMed ID: 2786368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response of subacute sclerosing panencephalitis patients to measles virus.
    Madden DL; Fuccillo DA; Castellano G; Traub R; Krezlewicz A; Sever JL
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):509-20. PubMed ID: 616551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells.
    Kreth HW; Wiegand G
    J Immunol; 1977 Jan; 118(1):296-301. PubMed ID: 830753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis.
    Hara T; Yamashita S; Aiba H; Nihei K; Koide N; Good RA; Takeshita K
    J Neurovirol; 2000 Apr; 6(2):121-6. PubMed ID: 10822325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-mediated cytotoxicity to viruses in patients with multiple sclerosis: presence of a blocking factor.
    Rola-Pleszczynski M; Abernathy M; Vincent MM; Hensen SA; Bellanti JA
    Clin Immunol Immunopathol; 1976 Mar; 5(2):165-72. PubMed ID: 1084246
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity.
    Labowskie R; Edelman R; Rustigian R; Bellanti JA
    J Infect Dis; 1974 Mar; 129(3):233-9. PubMed ID: 4816303
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of lymphocytes from subacute sclerosing panencephalitis patients by defined measles virus antigens.
    Ilonen J; Reunanen M; Herva E; Ziola B; Salmi A
    Cell Immunol; 1980 May; 51(2):201-14. PubMed ID: 6966188
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell mediated immunity in patients with subacute sclerosing panencephalitis.
    Aysun S; Sanal O; Renda Y; Berkel I; Yalaz K; Ersoy F; Ozdirim E
    Brain Dev; 1984; 6(4):391-6. PubMed ID: 6333831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis.
    Dhib-Jalbut S; McFarland HF; Mingioli ES; Sever JL; McFarlin DE
    J Virol; 1988 Jul; 62(7):2483-9. PubMed ID: 3373575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity in SSPE patients.
    Kreth HW; Kaeckell YM; ter Meulen V
    Med Microbiol Immunol; 1974; 160(2-3):191-9. PubMed ID: 4614050
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis.
    Hall WW; Lamb RA; Choppin PW
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2047-51. PubMed ID: 287042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [State of the cellular component of immunity in subacute sclerosing panencephalitis in children].
    Mitrokhina LA; Lebenzon SS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1478-80. PubMed ID: 6606914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines.
    Thurman GB; Ahmed A; Strong DM; Knudsen RC; Grace WR; Sell KW
    J Exp Med; 1973 Oct; 138(4):839-46. PubMed ID: 4355279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological studies on the etiological role of measles-like virus in subacute sclerosing panencephalitis.
    Polna I; Cendrowski W
    J Neurol; 1977 Nov; 216(4):301-10. PubMed ID: 72813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute sclerosing panencephalitis (SSPE).
    Lapointe N; Geoffroy G; McLaughlin B; Mongeau JG
    Birth Defects Orig Artic Ser; 1975; 11(1):239-43. PubMed ID: 1096980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.